Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)
NCT00684918
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
AML
Interventions
DRUG:
Obatoclax
Sponsor
Gemin X